Member
1 Award

RECORNEA SRL


RECORNEA is dedicated to restoring optimal vision for patients suffering from keratoconus and other corneal shape deformations through innovative medical devices. Their flagship product, the GROSSO® Implant, is designed to restore the physiological curvature of the cornea, providing clear and predictable clinical outcomes.

Industries

health-care
medical-device
therapeutics

Nr. of Employees

small (1-50)

RECORNEA SRL

Awards

Implantable nitinol corneal implant to combat corneal shape deformations and corneal traumas (NiTi4EYE)

Funding (ceiling)

$2,162,161.78

Award Year

2025


Patents

Corneal implant

2024-11-19 • US-12144722-B2

View Details

Corneal implant

2024-04-16 • US-11957568-B2

View Details

Corneal implant

2022-11-29 • US-11510775-B2

View Details

Products

Corneal nitinol implant (implantable dome-shaped corneal net)

An implantable dome-shaped corneal net made from medical-grade nitinol designed to restore physiological corneal curvature and address pathological corneal shape deformations such as keratoconus.

Expertise Areas

  • Corneal implant development
  • Ophthalmic implantable medical devices
  • Prototype design and fabrication
  • Preclinical and clinical validation of implants
  • Show More (2)

Key Technologies

  • Nitinol (medical-grade shape-memory alloy) for implants
  • Implantable corneal net/dome architecture
  • Ophthalmic implant prototyping
  • Preclinical and clinical validation methodologies
  • Show More (1)

News & Updates

Patents+ Grant

Recornea received the grant "Patents+" from the Italian Ministry of Economy (BRE0001128).

Capabilities


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.